股本结构
单位：万股
| 公告日期 | 2026-08-06 | 2026-07-22 | 2026-08-06 | 2026-05-20 | 2026-05-20 | 2026-02-06 |
|---|---|---|---|---|---|---|
| 证券总股本 | 20655.27 | 20640.23 | 20626.49 | 20530.89 | 20394.04 | 20353.22 |
| 普通股本 | 20655.27 | 20640.23 | 20626.49 | 20530.89 | 20394.04 | 20353.22 |
| 优先股 | 未披露 | 1.00 | 1.00 | 未披露 | 1.00 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2026-08-03 | 2026-07-08 | 2026-06-30 | 2026-05-14 | 2026-03-31 | 2026-02-02 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2026-08-06 | 20655.27 | 未披露 | 定期报告 | 2026-08-03 |
| 2026-07-22 | 20640.23 | 1.00 | 定期报告 | 2026-07-08 |
| 2026-08-06 | 20626.49 | 1.00 |
更多>>
From March 31,2026 to June 30,2026
Stock options exercised and restricted stock units vested and settled
|
2026-06-30 |
| 2026-05-20 | 20530.89 | 未披露 | 定期报告 | 2026-05-14 |
| 2026-05-20 | 20394.04 | 1.00 |
更多>>
From March 31, 2025 to March 31, 2026
Issuance of common stock upon underwritten offering
Stock options exercised and restricted stock units vested and settled
|
2026-03-31 |
| 2026-02-06 | 20353.22 | 未披露 | 定期报告 | 2026-02-02 |
| 2026-02-06 | 20331.69 | 1.00 |
更多>>
From September 30, 2025 to December 31, 2025
Issuance of common stock upon underwritten offering
Stock options exercised and restricted stock units vested and settled
|
2025-12-31 |
| 2025-12-12 | 20147.65 | 未披露 |
更多>>
Common Stock offered 26,200,000 shares by the company
|
2025-12-12 |
| 2025-11-10 | 17527.65 | 未披露 | 定期报告 | 2025-11-03 |
| 2025-11-10 | 17453.27 | 1.00 |
更多>>
From June 30, 2025 to September 30, 2025
Stock options exercised and restricted stock units vested and settled
|
2025-09-30 |
| 2025-08-11 | 17431.68 | 未披露 | 定期报告 | 2025-08-04 |
| 2025-08-11 | 17106.92 | 1.00 |
更多>>
From March 31, 2025 to June 30, 2025
Stock options exercised and restricted stock units vested and settled
|
2025-06-30 |
| 2025-07-09 | 17105.05 | 1.00 | 定期报告 | 2025-06-13 |
| 2025-05-29 | 17092.32 | 未披露 | 定期报告 | 2025-05-23 |
| 2025-05-29 | 17011.16 | 1.00 |
更多>>
From March 31, 2024 to March 31, 2025
Issuance of common stock upon private placement
Stock options exercised and restricted stock units vested and settled
|
2025-03-31 |
| 2025-02-06 | 16986.07 | 未披露 | 定期报告 | 2025-01-31 |
| 2025-01-13 | 16928.46 | 未披露 |
更多>>
The Company placed 22,500,000 common shares in a private placement.
|
2025-01-15 |
| 2025-02-06 | 14720.36 | 1.00 |
更多>>
From September 30, 2024 to December 31, 2024
Stock options exercised and restricted stock units vested and settled
|
2024-12-31 |
| 2024-11-07 | 14678.46 | 未披露 | 定期报告 | 2024-11-01 |
| 2024-11-07 | 14656.50 | 1.00 |
更多>>
From June 30,2024 to September 30,2024
Stock options exercised and restricted stock units vested and settled
|
2024-09-30 |
| 2024-08-06 | 14636.74 | 未披露 | 定期报告 | 2024-07-30 |
| 2024-08-06 | 14619.57 | 1.00 |
更多>>
From March 31, 2024 to June 30, 2024
Stock options exercised and restricted stock units vested and settled
|
2024-06-30 |
| 2024-06-26 | 14618.01 | 未披露 | 定期报告 | 2024-06-18 |
| 2024-06-26 | 14617.67 | 1.00 | 定期报告 | 2024-06-14 |
| 2024-05-29 | 14605.39 | 未披露 | 定期报告 | 2024-05-22 |
| 2024-05-29 | 14558.30 | 1.00 |
更多>>
From March 31, 2023 to March 31, 2024
Issuance of common stock upon underwritten public offering and private placement
Stock options exercised and restricted stock units vested and settled
|
2024-03-31 |
| 2024-02-12 | 14529.30 | 未披露 | 定期报告 | 2024-02-05 |
| 2024-02-12 | 14509.41 | 1.00 |
更多>>
From September 30,2023 to December 31,2023
Issuance of common stock upon underwritten public offering and private placement
Stock options exercised and restricted stock units vested and settled
|
2023-12-31 |
| 2023-11-09 | 14466.19 | 未披露 | 定期报告 | 2023-11-03 |
| 2023-09-29 | 13804.17 | 未披露 |
更多>>
Common stock offered 7,370,000 shares by the company
|
2023-10-02 |
| 2023-11-09 | 13144.20 | 1.00 |
更多>>
From June 30, 2023 to September 30, 2023
Stock options exercised and restricted stock units vested and settled
|
2023-09-30 |
| 2023-08-10 | 13067.17 | 未披露 | 定期报告 | 2023-08-04 |
| 2023-08-10 | 13056.54 | 1.00 |
更多>>
From March 31, 2023 to June 30, 2023
Stock options exercised and restricted stock units vested and settled
|
2023-06-30 |
| 2023-06-26 | 13056.27 | 1.00 | 定期报告 | 2023-06-15 |
| 2023-05-22 | 13040.84 | 未披露 | 定期报告 | 2023-05-17 |
| 2023-05-22 | 13032.99 | 1.00 |
更多>>
From March 31, 2022 to March 31, 2023
Issuance of common stock upon underwritten offering
Stock options exercised and restricted stock units vested and settled
|
2023-03-31 |
| 2023-02-03 | 13024.53 | 未披露 | 定期报告 | 2023-01-27 |
| 2023-02-03 | 12926.03 | 1.00 |
更多>>
From September 30, 2022 to December 31, 2022
Issuance of common stock upon underwritten offering
Stock options exercised and restricted stock units vested and settled
|
2022-12-31 |
| 2022-11-04 | 12918.25 | 未披露 | 定期报告 | 2022-10-28 |
| 2022-10-05 | 12911.41 | 未披露 |
更多>>
Common stock offered by 12,500,000 shares
|
2022-10-06 |
| 2022-11-04 | 11661.41 | 1.00 |
更多>>
From June 30, 2022 to September 30, 2022
Restricted stock units vested and settled
|
2022-09-30 |
| 2022-08-05 | 11657.72 | 未披露 | 定期报告 | 2022-07-29 |
| 2022-08-05 | 11652.42 | 1.00 |
更多>>
From March 31, 2022 to June 30, 2022
Stock options exercised and restricted stock units vested and settled
|
2022-06-30 |
| 2022-06-30 | 11651.64 | 未披露 | 定期报告 | 2022-06-15 |
| 2022-06-08 | 11650.54 | 未披露 | 定期报告 | 2022-06-03 |
| 2022-06-08 | 11648.29 | 1.00 |
更多>>
From March 31, 2021 to March 31, 2022
Issuance of common stock upon investment by Roivant Sciences Ltd.
Restricted stock units vested and settled
|
2022-03-31 |
| 2022-02-04 | 11639.57 | 未披露 | 定期报告 | 2022-02-01 |
| 2022-02-04 | 11510.98 | 1.00 |
更多>>
From September 30, 2021 to December 31, 2021
Restricted stock units vested and settled
|
2021-12-31 |
| 2021-11-05 | 11500.02 | 未披露 | 定期报告 | 2021-11-01 |
| 2021-11-05 | 11499.89 | 1.00 |
更多>>
From June 30, 2021 to September 30, 2021
Issuance of common stock upon investment by Roivant Sciences Ltd.
|
2021-09-30 |
| 2021-08-09 | 11499.89 | 未披露 | 定期报告 | 2021-08-09 |
| 2021-08-09 | 9797.76 | 1.00 |
更多>>
From March 31, 2021 to June 30, 2021
Restricted stock units vested and settled
|
2021-06-30 |
| 2021-06-01 | 9797.67 | 未披露 | 定期报告 | 2021-06-01 |
| 2021-06-01 | 9797.12 | 未披露 |
更多>>
From March 31, 2020 To March 31, 2021
Issuance of common stock upon underwritten public offerings
Issuance of common stock upon achievement of earnout shares milestones
Vesting of sponsor restricted shares
Issuance of common stock upon warrants redemption
Stock options exercised and vesting of restricted stock units
|
2021-03-31 |
| 2021-02-16 | 9797.12 | 1.00 |
更多>>
From September 30, 2020 To December 31, 2020
Stock options exercised and vesting of restricted stock units
|
2020-12-31 |
| 2020-11-12 | 9789.07 | 1.00 |
更多>>
From June 30, 2020 to September 30, 2020
Issuance of common stock upon underwritten public offering
Issuance of common stock upon achievement of earnout shares milestone
Vesting of sponsor restricted shares
Stock options exercised
|
2020-09-30 |
| 2020-09-04 | 8708.18 | 未披露 |
更多>>
1.Common stock offered by the company 5,270,093 shares.
2.The number of shares of common stock to be outstanding after this offering set forth above is based on 81,811,727 shares of common stock outstanding as of June 30, 2020.
|
2020-09-04 |
| 2020-08-31 | 8181.17 | 1.00 |
更多>>
From March 31, 2020 to June 30, 2020
Issuance of common stock upon underwritten public offering
Issuance of common stock upon achievement of earnout shares milestone
Vesting of sponsor restricted shares
Issuance of common stock upon warrant redemption
Stock options exercised
|
2020-06-30 |
| 2020-07-09 | 8181.17 | 未披露 | 定期报告 | 2020-06-22 |
| 2020-04-16 | 6481.48 | 未披露 |
更多>>
1.Common stock offered by us 8,359,448 shares
2.The number of shares of our common stock to be outstanding after this offering set forth above is based on 56,455,376 shares of our common stock outstanding as of December 31, 2019
|
2020-04-16 |
| 2020-06-29 | 5465.54 | 1.00 |
更多>>
From March 31, 2019 to March 31, 2020
Issuance of preferred and common stock, net of deferred offering costs upon Business Combination and Recapitalization
Conversion of convertible promissory notes
|
2020-03-31 |
| 2020-02-28 | 5439.96 | 未披露 | 定期报告 | 2020-02-15 |
| 2020-02-14 | 5645.54 | 未披露 | 定期报告 | 2020-02-14 |
| 2020-02-14 | 5465.54 | 1.00 |
更多>>
From September 30, 2019 to December 31, 2019
Issuance of preferred and common stock, net of deferred offering costs upon Business Combination & Recapitalization
Conversion of convertible promissory notes
|
2019-12-31 |
| 2020-01-19 | 5645.54 | 未披露 | 定期报告 | 2019-12-18 |
| 2019-08-12 | 1437.50 | 未披露 |
更多>>
From March 31, 2019 to June 30, 2019
Sale of 11,500,000 Units, net of underwriting discounts and offering costs
Common stock subject to possible redemption
|
2019-06-30 |
| 2019-06-21 | 1250.00 | 未披露 | 定期报告 | 2019-06-21 |
| 2019-04-16 | 287.50 | 未披露 | 定期报告 | 2018-12-31 |
From March 31,2026 to June 30,2026
Stock options exercised and restricted stock units vested and settled
From March 31, 2025 to March 31, 2026
Issuance of common stock upon underwritten offering
Stock options exercised and restricted stock units vested and settled
From September 30, 2025 to December 31, 2025
Issuance of common stock upon underwritten offering
Stock options exercised and restricted stock units vested and settled
Common Stock offered 26,200,000 shares by the company
From June 30, 2025 to September 30, 2025
Stock options exercised and restricted stock units vested and settled
From March 31, 2025 to June 30, 2025
Stock options exercised and restricted stock units vested and settled
From March 31, 2024 to March 31, 2025
Issuance of common stock upon private placement
Stock options exercised and restricted stock units vested and settled
The Company placed 22,500,000 common shares in a private placement.
From September 30, 2024 to December 31, 2024
Stock options exercised and restricted stock units vested and settled
From June 30,2024 to September 30,2024
Stock options exercised and restricted stock units vested and settled
From March 31, 2024 to June 30, 2024
Stock options exercised and restricted stock units vested and settled
From March 31, 2023 to March 31, 2024
Issuance of common stock upon underwritten public offering and private placement
Stock options exercised and restricted stock units vested and settled
From September 30,2023 to December 31,2023
Issuance of common stock upon underwritten public offering and private placement
Stock options exercised and restricted stock units vested and settled
Common stock offered 7,370,000 shares by the company
From June 30, 2023 to September 30, 2023
Stock options exercised and restricted stock units vested and settled
From March 31, 2023 to June 30, 2023
Stock options exercised and restricted stock units vested and settled
From March 31, 2022 to March 31, 2023
Issuance of common stock upon underwritten offering
Stock options exercised and restricted stock units vested and settled
From September 30, 2022 to December 31, 2022
Issuance of common stock upon underwritten offering
Stock options exercised and restricted stock units vested and settled
Common stock offered by 12,500,000 shares
From June 30, 2022 to September 30, 2022
Restricted stock units vested and settled
From March 31, 2022 to June 30, 2022
Stock options exercised and restricted stock units vested and settled
From March 31, 2021 to March 31, 2022
Issuance of common stock upon investment by Roivant Sciences Ltd.
Restricted stock units vested and settled
From September 30, 2021 to December 31, 2021
Restricted stock units vested and settled
From June 30, 2021 to September 30, 2021
Issuance of common stock upon investment by Roivant Sciences Ltd.
From March 31, 2021 to June 30, 2021
Restricted stock units vested and settled
From March 31, 2020 To March 31, 2021
Issuance of common stock upon underwritten public offerings
Issuance of common stock upon achievement of earnout shares milestones
Vesting of sponsor restricted shares
Issuance of common stock upon warrants redemption
Stock options exercised and vesting of restricted stock units
From September 30, 2020 To December 31, 2020
Stock options exercised and vesting of restricted stock units
From June 30, 2020 to September 30, 2020
Issuance of common stock upon underwritten public offering
Issuance of common stock upon achievement of earnout shares milestone
Vesting of sponsor restricted shares
Stock options exercised
1.Common stock offered by the company 5,270,093 shares.
2.The number of shares of common stock to be outstanding after this offering set forth above is based on 81,811,727 shares of common stock outstanding as of June 30, 2020.
From March 31, 2020 to June 30, 2020
Issuance of common stock upon underwritten public offering
Issuance of common stock upon achievement of earnout shares milestone
Vesting of sponsor restricted shares
Issuance of common stock upon warrant redemption
Stock options exercised
1.Common stock offered by us 8,359,448 shares
2.The number of shares of our common stock to be outstanding after this offering set forth above is based on 56,455,376 shares of our common stock outstanding as of December 31, 2019
From March 31, 2019 to March 31, 2020
Issuance of preferred and common stock, net of deferred offering costs upon Business Combination and Recapitalization
Conversion of convertible promissory notes
From September 30, 2019 to December 31, 2019
Issuance of preferred and common stock, net of deferred offering costs upon Business Combination & Recapitalization
Conversion of convertible promissory notes
From March 31, 2019 to June 30, 2019
Sale of 11,500,000 Units, net of underwriting discounts and offering costs
Common stock subject to possible redemption